HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
111738.0,207547,2166-11-07 06:49:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Clopidogrel 75 mg daily
   ASA 325mg
   Atorvostatin 80mg daily
   Metoprolol 37.5mg TID
   Warfarin 2mg daily
   Senna
   Docusate
   Exelon
   Namenda
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-7**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 78 (58 - 78) bpm
   BP: 147/77(95) {100/41(56) - 147/78(95)} mmHg
   RR: 14 (10 - 20) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                    438 mL
                                                                    500 mL
   PO:
                                                                    350 mL
             TF:
   IVF:
                                                                     88 mL
                                                                    500 mL
   Blood products:
   Total out:
                                                                    550 mL
                                                                    400 mL
   Urine:
                                                                    550 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -112 mL
                                                                    100 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   GENERAL: NAD. Oriented x2. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. mild crackles at the bases no
   wheezes or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.
   SKIN: No venoous stasis changes ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ PT 1+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   487 K/uL
   12.6 g/dL
   103 mg/dL
   1.0 mg/dL
   25 mEq/L
   5.0 mEq/L
   17 mg/dL
   109 mEq/L
   142 mEq/L
   37.9 %
   10.0 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
   WBC
   10.0
   Hct
   37.9
   Plt
   406
   487
   Cr
   1.0
   TropT
   1.00
   Glucose
   103
   Other labs: PT / PTT / INR:29.2/29.7/2.9, CK / CKMB /
   Troponin-T:247/17/1.00, Ca++:7.9 mg/dL, Mg++:1.8 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   .
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Pt currently CP free.
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - holding ACEI given Cr 1.3 and unknown baseline. Will trend and
   restart in AM if Cr stable
   - trend CE
   - TTE in AM
   - ECG in AM
   - monitor on tele
   - post-cath check tonight
   .
   # PUMP: euvolemic on exam
   - TTE in AM
   - consider restarting ACEI
   .
   # RHYTHM: sinus
   - monitor on tele
   .
   # Hyperkalemia: K was 5.6 on admission and sample not hemolyzed. ECG no
   changes concerning for hyperkalemia.
   - recheck K
   - kayexalate x1
   - monitor on tele
   .
   # CRI: Unclear baseline and whether this is an acute change. Likely
   chronic given history of HTN.
   - holding ACEI for now and will restart in AM if stable
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   .
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   .
   # Dementia: pt at baseline
   - cont home meds
   .
   FEN: Cardiac
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   .
   CODE: FULL- confirmed with wife
   .
   COMM: Wife: [**Telephone/Fax (1) 12064**]
   .
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Clopidogrel 75 mg daily
   ASA 325mg
   Atorvostatin 80mg daily
   Metoprolol 37.5mg TID
   Warfarin 2mg daily
   Senna
   Docusate
   Exelon
   Namenda
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-7**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 78 (58 - 78) bpm
   BP: 147/77(95) {100/41(56) - 147/78(95)} mmHg
   RR: 14 (10 - 20) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                    438 mL
                                                                    500 mL
   PO:
                                                                    350 mL
             TF:
   IVF:
                                                                     88 mL
                                                                    500 mL
   Blood products:
   Total out:
                                                                    550 mL
                                                                    400 mL
   Urine:
                                                                    550 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -112 mL
                                                                    100 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   GENERAL: NAD. Oriented x2. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. mild crackles at the bases no
   wheezes or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.
   SKIN: No venoous stasis changes ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ PT 1+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   487 K/uL
   12.6 g/dL
   103 mg/dL
   1.0 mg/dL
   25 mEq/L
   5.0 mEq/L
   17 mg/dL
   109 mEq/L
   142 mEq/L
   37.9 %
   10.0 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
   WBC
   10.0
   Hct
   37.9
   Plt
   406
   487
   Cr
   1.0
   TropT
   1.00
   Glucose
   103
   Other labs: PT / PTT / INR:29.2/29.7/2.9, CK / CKMB /
   Troponin-T:247/17/1.00, Ca++:7.9 mg/dL, Mg++:1.8 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   .
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Pt currently CP free.
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - holding ACEI given Cr 1.3 and unknown baseline. Will trend and
   restart in AM if Cr stable
   - trend CE
   - TTE in AM
   - ECG in AM
   - monitor on tele
   - post-cath check tonight
   .
   # PUMP: euvolemic on exam
   - TTE in AM
   - consider restarting ACEI
   .
   # RHYTHM: sinus
   - monitor on tele
   .
   # Hyperkalemia: K was 5.6 on admission and sample not hemolyzed. ECG no
   changes concerning for hyperkalemia.
   - recheck K
   - kayexalate x1
   - monitor on tele
   .
   # CRI: Unclear baseline and whether this is an acute change. Likely
   chronic given history of HTN.
   - holding ACEI for now and will restart in AM if stable
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   .
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   .
   # Dementia: pt at baseline
   - cont home meds
   .
   FEN: Cardiac
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   .
   CODE: FULL- confirmed with wife
   .
   COMM: Wife: [**Telephone/Fax (1) 12064**]
   .
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 88-year-old male with a significant medical history, including hypertension, stroke, and deep vein thrombosis (DVT). He was admitted with a diagnosis of ST-segment elevation myocardial infarction (STEMI) and underwent percutaneous coronary intervention (PCI) with placement of a bare-metal stent in the mid-left anterior descending (LAD) coronary artery.

The patient's current vital signs are stable, with a temperature of 37.4°C, heart rate of 78 beats per minute, and blood pressure of 147/77 mmHg. His respiratory rate is 14 breaths per minute, and oxygen saturation is 98% on nasal cannula.

The patient's physical examination reveals a normal cardiovascular examination, with no murmurs, gallop rhythms, or thrill. His lung examination is normal, with no wheezing or rhonchi. His abdominal examination is normal, with no tenderness or masses.

Laboratory results show a white blood cell count of 10.0 K/μL, hemoglobin of 12.6 g/dL, and platelet count of 406 K/μL. His creatinine level is 1.0 mg/dL, and his troponin-T level is 1.00 ng/mL.

The patient's medical plan includes continued treatment with aspirin, clopidogrel, atorvastatin, metoprolol, warfarin, and other medications as needed. He will also receive prophylaxis for deep vein thrombosis, stress ulcers, and ventilator-associated pneumonia.

Potential medical complications that may arise include:

1. Cardiac complications: The patient's history of STEMI and PCI may increase his risk of cardiac complications, such as arrhythmias, heart failure, or cardiac arrest.
2. Bleeding complications: The patient's use of anticoagulant medications, such as warfarin, and antiplatelet agents, such as clopidogrel, may increase his risk of bleeding complications.
3. Renal complications: The patient's history of hypertension and DVT may increase his risk of renal complications, such as acute kidney injury or chronic kidney disease.
4. Neurological complications: The patient's history of stroke and dementia may increase his risk of neurological complications, such as seizures or cerebral edema.
5. Infection complications: The patient's use of invasive devices, such as central lines and urinary catheters, may increase his risk of infection complications, such as sepsis or bacteremia.
6. Hyperkalemia: The patient's history of hypertension and use of medications that may cause hyperkalemia, such as potassium-sparing diuretics, may increase his risk of hyperkalemia.

Overall, the patient's condition is stable, but he requires close monitoring and management to prevent potential complications."
111738.0,207547,2166-11-07 06:49:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   This morning, complained of persistent back, shoulder discomfort with
   chest tightness.  EKG showed evolving ST changes in anterior leads and
   patient hyperadrenergic with elevated heart rate and blood pressure.
   Started transiently on nitro gtt until pain resolved.  After developed
   marginal blood pressure with SBP in 80s.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Clopidogrel 75 mg daily
   ASA 325mg
   Atorvostatin 80mg daily
   Metoprolol 37.5mg TID
   Warfarin 2mg daily
   Senna
   Docusate
   Exelon
   Namenda
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-7**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 78 (58 - 78) bpm
   BP: 147/77(95) {100/41(56) - 147/78(95)} mmHg
   RR: 14 (10 - 20) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                    438 mL
                                                                    500 mL
   PO:
                                                                    350 mL
             TF:
   IVF:
                                                                     88 mL
                                                                    500 mL
   Blood products:
   Total out:
                                                                    550 mL
                                                                    400 mL
   Urine:
                                                                    550 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -112 mL
                                                                    100 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   GENERAL: NAD. Oriented x2. Appears anxious.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. S4. No m/r/g. No thrills, lifts.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. mild crackles at the bases no
   wheezes or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.
   SKIN: No venoous stasis changes ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ PT 1+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   487 K/uL
   12.6 g/dL
   103 mg/dL
   1.0 mg/dL
   25 mEq/L
   5.0 mEq/L
   17 mg/dL
   109 mEq/L
   142 mEq/L
   37.9 %
   10.0 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
   WBC
   10.0
   Hct
   37.9
   Plt
   406
   487
   Cr
   1.0
   TropT
   1.00
   Glucose
   103
   Other labs: PT / PTT / INR:29.2/29.7/2.9, CK / CKMB /
   Troponin-T:247/17/1.00, Ca++:7.9 mg/dL, Mg++:1.8 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   .
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - trend CE
   - TTE in AM
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   .
   # PUMP: euvolemic on exam
   - TTE in AM
   - restart ACEI
   .
   # RHYTHM: sinus
   - monitor on tele
   .
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   .
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   .
   # Dementia: pt at baseline
   - cont home meds
   .
   FEN: Cardiac
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   .
   CODE: FULL- confirmed with wife
   .
   COMM: Wife: [**Telephone/Fax (1) 12064**]
   .
   DISPO: CCU for now
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   This morning, complained of persistent back, shoulder discomfort with
   chest tightness.  EKG showed evolving ST changes in anterior leads and
   patient hyperadrenergic with elevated heart rate and blood pressure.
   Started transiently on nitro gtt until pain resolved.  After developed
   marginal blood pressure with SBP in 80s.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Clopidogrel 75 mg daily
   ASA 325mg
   Atorvostatin 80mg daily
   Metoprolol 37.5mg TID
   Warfarin 2mg daily
   Senna
   Docusate
   Exelon
   Namenda
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-7**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 78 (58 - 78) bpm
   BP: 147/77(95) {100/41(56) - 147/78(95)} mmHg
   RR: 14 (10 - 20) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                    438 mL
                                                                    500 mL
   PO:
                                                                    350 mL
             TF:
   IVF:
                                                                     88 mL
                                                                    500 mL
   Blood products:
   Total out:
                                                                    550 mL
                                                                    400 mL
   Urine:
                                                                    550 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -112 mL
                                                                    100 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   GENERAL: NAD. Oriented x2. Appears anxious.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. S4. No m/r/g. No thrills, lifts.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. mild crackles at the bases no
   wheezes or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.
   SKIN: No venoous stasis changes ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ PT 1+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   487 K/uL
   12.6 g/dL
   103 mg/dL
   1.0 mg/dL
   25 mEq/L
   5.0 mEq/L
   17 mg/dL
   109 mEq/L
   142 mEq/L
   37.9 %
   10.0 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
   WBC
   10.0
   Hct
   37.9
   Plt
   406
   487
   Cr
   1.0
   TropT
   1.00
   Glucose
   103
   Other labs: PT / PTT / INR:29.2/29.7/2.9, CK / CKMB /
   Troponin-T:247/17/1.00, Ca++:7.9 mg/dL, Mg++:1.8 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   .
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - trend CE
   - TTE in AM
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   .
   # PUMP: euvolemic on exam
   - TTE in AM
   - restart ACEI
   .
   # RHYTHM: sinus
   - monitor on tele
   .
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   .
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   .
   # Dementia: pt at baseline
   - cont home meds
   .
   FEN: Cardiac
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   .
   CODE: FULL- confirmed with wife
   .
   COMM: Wife: [**Telephone/Fax (1) 12064**]
   .
   DISPO: CCU for now<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, here is a summary of the information:

The patient is an 88-year-old male who presented with anterior STEMI and was taken to the cath lab for BMS placement to an 80% thrombotic mid-LAD lesion. He has a history of hypertension, stroke, and DVT, and is currently on various medications including aspirin, clopidogrel, atorvastatin, metoprolol, warfarin, and senna.

The patient's current vital signs include a temperature of 37.4°C, heart rate of 78 bpm, blood pressure of 147/77 mmHg, and respiratory rate of 14 inspirations per minute. His oxygen saturation is 98% on nasal cannula. His physical examination reveals a patient who appears anxious, with no signs of chest wall deformities, scoliosis, or kyphosis.

Laboratory results show a white blood cell count of 10.0 K/uL, hemoglobin of 12.6 g/dL, and creatinine of 1.0 mg/dL. His troponin-T level is 1.00 ng/mL, and his glucose level is 103 mg/dL.

The patient's plan includes continuation of his current medications, with the addition of metoprolol 37.5mg TID and restarting lisinopril. He will also have a TTE in the morning and will be monitored on telemetry.

Potential medical complications that can arise include:

1. Recurrent ischemia: The patient's recurrent chest pain is concerning for recurrent ischemia, which can lead to further myocardial infarction or cardiac arrhythmias.
2. Heart failure: The patient's euvolemic status on examination may not persist, and he may develop heart failure due to his underlying cardiac conditions.
3. Renal dysfunction: The patient's creatinine level has improved, but he has a history of hypertension and may be at risk for renal dysfunction, particularly with the use of nephrotoxic medications.
4. Bleeding complications: The patient is taking warfarin and clopidogrel, which may increase his risk of bleeding complications, particularly in the setting of gastrointestinal bleeding or intracranial hemorrhage.
5. DVT: The patient has a history of DVT and is currently on coumadin, which may increase his risk of bleeding complications."
111738.0,207547,2166-11-07 06:49:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   This morning, complained of persistent back, shoulder discomfort with
   chest tightness.  EKG showed evolving ST changes in anterior leads and
   patient hyperadrenergic with elevated heart rate and blood pressure.
   Started transiently on nitro gtt until pain resolved.  After developed
   marginal blood pressure with SBP in 80s.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Clopidogrel 75 mg daily
   ASA 325mg
   Atorvostatin 80mg daily
   Metoprolol 37.5mg TID
   Warfarin 2mg daily
   Senna
   Docusate
   Exelon
   Namenda
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-7**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 78 (58 - 78) bpm
   BP: 147/77(95) {100/41(56) - 147/78(95)} mmHg
   RR: 14 (10 - 20) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                    438 mL
                                                                    500 mL
   PO:
                                                                    350 mL
             TF:
   IVF:
                                                                     88 mL
                                                                    500 mL
   Blood products:
   Total out:
                                                                    550 mL
                                                                    400 mL
   Urine:
                                                                    550 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -112 mL
                                                                    100 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   GENERAL: NAD. Oriented x2. Appears anxious.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. S4. No m/r/g. No thrills, lifts.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. mild crackles at the bases no
   wheezes or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.
   SKIN: No venoous stasis changes ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ PT 1+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   487 K/uL
   12.6 g/dL
   103 mg/dL
   1.0 mg/dL
   25 mEq/L
   5.0 mEq/L
   17 mg/dL
   109 mEq/L
   142 mEq/L
   37.9 %
   10.0 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
   WBC
   10.0
   Hct
   37.9
   Plt
   406
   487
   Cr
   1.0
   TropT
   1.00
   Glucose
   103
   Other labs: PT / PTT / INR:29.2/29.7/2.9, CK / CKMB /
   Troponin-T:247/17/1.00, Ca++:7.9 mg/dL, Mg++:1.8 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   .
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - trend CE
   - TTE in AM
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   .
   # PUMP: euvolemic on exam
   - TTE in AM
   - restart ACEI
   .
   # RHYTHM: sinus
   - monitor on tele
   .
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   .
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   .
   # Dementia: pt at baseline
   - cont home meds
   .
   FEN: Cardiac
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   .
   CODE: FULL- confirmed with wife
   .
   COMM: Wife: [**Telephone/Fax (1) 12064**]
   .
   DISPO: CCU for now
   ------ Protected Section ------
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I have also reviewed the notes of Dr(s). [**Name (NI) **].
   I would add the following remarks:
   History
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion. Cath showed and 80% hazy mid LAD lesion that was
   stented with a BMS. Additionally there was an 80% RI and 90% LCx and
   80% mid RCA lesion. He continued to have low grade chest pain overnight
   and is pain free this morning. CK up to 247 thus far. Hct, BUN and
   creat stable
   Medical Decision Making
   88 male here with anterior STEMI aborted with BMS to LAD. Patient has
   lesions in the RCA, RI and LCx which require intervention. Will
   increase Metoprolol to 37.5 [**Hospital1 7**] and ACEI as BP tolerates. He will
   remain on coumadin for h/o DVT/PE. Ok to floor later today. Continue to
   trend enzymes.
   Above discussed extensively with patient. I have discussed this plan
   with Dr(s). [**Name (NI) **] and Pride.
   Total time spent on patient care: 40 minutes of critical care time.
   ------ Protected Section Addendum Entered By:[**Name (NI) 861**] [**Last Name (NamePattern1) **], MD
   on:[**2166-11-7**] 07:59 PM ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   This morning, complained of persistent back, shoulder discomfort with
   chest tightness.  EKG showed evolving ST changes in anterior leads and
   patient hyperadrenergic with elevated heart rate and blood pressure.
   Started transiently on nitro gtt until pain resolved.  After developed
   marginal blood pressure with SBP in 80s.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Clopidogrel 75 mg daily
   ASA 325mg
   Atorvostatin 80mg daily
   Metoprolol 37.5mg TID
   Warfarin 2mg daily
   Senna
   Docusate
   Exelon
   Namenda
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-7**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 78 (58 - 78) bpm
   BP: 147/77(95) {100/41(56) - 147/78(95)} mmHg
   RR: 14 (10 - 20) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                    438 mL
                                                                    500 mL
   PO:
                                                                    350 mL
             TF:
   IVF:
                                                                     88 mL
                                                                    500 mL
   Blood products:
   Total out:
                                                                    550 mL
                                                                    400 mL
   Urine:
                                                                    550 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -112 mL
                                                                    100 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   GENERAL: NAD. Oriented x2. Appears anxious.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. S4. No m/r/g. No thrills, lifts.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. mild crackles at the bases no
   wheezes or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.
   SKIN: No venoous stasis changes ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ PT 1+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   487 K/uL
   12.6 g/dL
   103 mg/dL
   1.0 mg/dL
   25 mEq/L
   5.0 mEq/L
   17 mg/dL
   109 mEq/L
   142 mEq/L
   37.9 %
   10.0 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
   WBC
   10.0
   Hct
   37.9
   Plt
   406
   487
   Cr
   1.0
   TropT
   1.00
   Glucose
   103
   Other labs: PT / PTT / INR:29.2/29.7/2.9, CK / CKMB /
   Troponin-T:247/17/1.00, Ca++:7.9 mg/dL, Mg++:1.8 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   .
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - trend CE
   - TTE in AM
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   .
   # PUMP: euvolemic on exam
   - TTE in AM
   - restart ACEI
   .
   # RHYTHM: sinus
   - monitor on tele
   .
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   .
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   .
   # Dementia: pt at baseline
   - cont home meds
   .
   FEN: Cardiac
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   .
   CODE: FULL- confirmed with wife
   .
   COMM: Wife: [**Telephone/Fax (1) 12064**]
   .
   DISPO: CCU for now
   ------ Protected Section ------
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I have also reviewed the notes of Dr(s). [**Name (NI) **].
   I would add the following remarks:
   History
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion. Cath showed and 80% hazy mid LAD lesion that was
   stented with a BMS. Additionally there was an 80% RI and 90% LCx and
   80% mid RCA lesion. He continued to have low grade chest pain overnight
   and is pain free this morning. CK up to 247 thus far. Hct, BUN and
   creat stable
   Medical Decision Making
   88 male here with anterior STEMI aborted with BMS to LAD. Patient has
   lesions in the RCA, RI and LCx which require intervention. Will
   increase Metoprolol to 37.5 [**Hospital1 7**] and ACEI as BP tolerates. He will
   remain on coumadin for h/o DVT/PE. Ok to floor later today. Continue to
   trend enzymes.
   Above discussed extensively with patient. I have discussed this plan
   with Dr(s). [**Name (NI) **] and Pride.
   Total time spent on patient care: 40 minutes of critical care time.
   ------ Protected Section Addendum Entered By:[**Name (NI) 861**] [**Last Name (NamePattern1) **], MD
   on:[**2166-11-7**] 07:59 PM ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 88-year-old male with a history of hypertension, stroke, and deep vein thrombosis (DVT) on coumadin, who presented with a STEMI and underwent a BMS to 80% thrombotic mid-LAD lesion. The patient has a history of dementia and is currently taking various medications, including clopidogrel, ASA, atorvastatin, metoprolol, warfarin, senna, docusate, Exelon, and Namenda.

The patient's current vital signs are:

* Temperature: 37.4°C (99.4°F)
* Heart rate: 78 bpm (58-78 bpm)
* Blood pressure: 147/77 mmHg (95-147/78 mmHg)
* Respiratory rate: 14 breaths per minute (10-20 breaths per minute)
* SpO2: 98%
* Heart rhythm: Sinus rhythm

The patient's physical examination is notable for a PMI located in the 5th intercostal space, midclavicular line, with a normal S1 and S2 heart sounds, and mild crackles at the bases of the lungs.

Laboratory results show:

* White blood cell count: 10.0 K/uL
* Hematocrit: 37.9%
* Platelet count: 406 K/uL
* Creatinine: 1.0 mg/dL
* Troponin-T: 1.00 ng/mL
* Glucose: 103 mg/dL

The patient's medical conditions include:

* Coronary artery disease with a history of STEMI and BMS placement
* Hypertension
* DVT on coumadin
* Dementia
* Chronic kidney disease with a creatinine level of 1.0 mg/dL

The patient's current medications include:

* Clopidogrel 75 mg daily
* ASA 325 mg daily
* Atorvastatin 80 mg daily
* Metoprolol 37.5 mg TID
* Warfarin 2 mg daily
* Senna
* Docusate
* Exelon
* Namenda

Based on the patient's medical conditions and laboratory results, potential medical complications that can arise include:

* Recurrent ischemia or infarction due to residual coronary artery disease
* Hypertension or hypotension due to medication or underlying conditions
* DVT or PE due to immobility or underlying conditions
* Kidney disease or failure due to medication or underlying conditions
* Dementia-related complications, such as falls or infections
* Bleeding or hemorrhage due to anticoagulation therapy

The patient's plan of care includes:

* Monitoring of vital signs and laboratory results
* Medication management, including adjustment of anticoagulation therapy and blood pressure management
* Pain management with morphine and nitroglycerin
* TTE in the morning to monitor cardiac function
* Restart of ACEI and lisinopril
* Monitoring of creatinine and electrolytes
* Avoidance of nephrotoxins and renally-dosed medications
* Continued management of dementia-related symptoms
* Monitoring of INR and T&S for DVT/PE prophylaxis

Overall, the patient requires close monitoring and management to prevent and treat potential complications, and to optimize his cardiac and kidney function."
111738.0,207547,2166-11-08 06:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - CP in AM, followed by increasing CK, peaked at 1147, MB at 113
   - ECHO: moderate regional LV systolic dysfxn with akinesis of the mid-
   and distal anterior wall and septum, apex and distal inferior segment
   (mid-LAD territory). LVEF = 35%
   - wasn't urinating, inserted foley
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2166-11-7**] 09:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-8**] 06:52 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 68 (61 - 100) bpm
   BP: 117/58(72) {85/42(58) - 165/87(104)} mmHg
   RR: 13 (12 - 24) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
                  Total In:
                                                                  2,726 mL
                                                                    120 mL
   PO:
                                                                  1,720 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  1,006 mL
   Blood products:
   Total out:
                                                                    875 mL
                                                                    450 mL
   Urine:
                                                                    875 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,851 mL
                                                                   -330 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///27/
   Physical Examination
   Gen: well appearing male, appears stated age
   Neck: JVD flat
   CV: RRR, Nl S1 S2. no mrg
   Lungs: clear to auscultation bilaterally.  No rales, wheezes, rhonchi.
   Abd: soft, ND, NT ABS
   Ext: wwp, palpable DP pulses
   Neuro: Alert and oriented to person
   Labs / Radiology
   510 K/uL
   12.2 g/dL
   107 mg/dL
   1.1 mg/dL
   27 mEq/L
   4.4 mEq/L
   20 mg/dL
   106 mEq/L
   140 mEq/L
   36.5 %
   11.1 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
                            [**2166-11-8**]  05:20 AM
   WBC
   10.0
   11.1
   Hct
   37.9
   36.5
   Plt
   [**Telephone/Fax (3) 12094**]
   Cr
   1.0
   1.1
   TropT
   1.00
   2.81
   Glucose
   103
   107
   Other labs: PT / PTT / INR:31.3/30.2/3.1, CK / CKMB /
   Troponin-T:731/44/2.81, Ca++:8.4 mg/dL, Mg++:1.9 mg/dL, PO4:2.6 mg/dL
   Imaging: ECHO:The left atrium is mildly dilated. There is mild
   symmetric left ventricular hypertrophy with normal cavity size. There
   is moderate regional left ventricular systolic dysfunction with
   akinesis of the mid- and distal anterior wall and septum, apex and
   distal inferior segment (mid-LAD territory). The remaining segments
   contract normally (LVEF = 35%). The LV apex is not visualized
   sufficiently for a thrombus to be definitely excluded, although one is
   not seen. Right ventricular chamber size and free wall motion are
   normal. The ascending aorta is mildly dilated. The aortic arch is
   mildly dilated. The aortic valve leaflets (3) are mildly thickened but
   aortic stenosis is not present. No aortic regurgitation is seen. The
   mitral valve leaflets are mildly thickened. Mild (1+) mitral
   regurgitation is seen. There is mild pulmonary artery systolic
   hypertension. There is no pericardial effusion.
   Microbiology: no new micro
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort.
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - start imdur 15mg today and uptitrate
   - morphine, nitro gtt, repeat EKG if pain recurs
   - intervention as outpt
   # PUMP: euvolemic on exam.
   - cont BB, ACEI, Imdur
   # RHYTHM: sinus
   - monitor on tele
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   # Dementia: pt at baseline
   - cont home meds
   FEN: Cardiac
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   CODE: FULL- confirmed with wife
   [**Name (NI) **]: Wife: [**Telephone/Fax (1) 12064**]
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I have also reviewed the notes of Dr(s). [**Name (NI) 2351**] and Pride.
   I would add the following remarks:
   Medical Decision Making
   CK peaked overnight at 1147 and the patient has no further chest pain.
   Echo shows mid to distal ant wall and septum are HK with EF 30-35% s/p
   LAD stenting for ASMI. He continue to have significant lesions in the
   LCx and RCA. He is intermittently confused and quite dysarthric. INR is
   3.1 to prevent mural thrombus. For CAD will continue ASA, Plavix, BB
   and Lisinopril 10 mg QD. Will add nitrates and plan to have the patient
   back in 1 month to stent the RCA and LCx. GI prophylaxis for coumadin,
   PLavix and ASA.
   Above discussed extensively with patient. I have discussed this plan
   with Dr(s). [**Name (NI) 2351**] and Pride.
   Total time spent on patient care: 40 minutes of critical care time.
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - CP in AM, followed by increasing CK, peaked at 1147, MB at 113
   - ECHO: moderate regional LV systolic dysfxn with akinesis of the mid-
   and distal anterior wall and septum, apex and distal inferior segment
   (mid-LAD territory). LVEF = 35%
   - wasn't urinating, inserted foley
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2166-11-7**] 09:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-8**] 06:52 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 68 (61 - 100) bpm
   BP: 117/58(72) {85/42(58) - 165/87(104)} mmHg
   RR: 13 (12 - 24) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
                  Total In:
                                                                  2,726 mL
                                                                    120 mL
   PO:
                                                                  1,720 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  1,006 mL
   Blood products:
   Total out:
                                                                    875 mL
                                                                    450 mL
   Urine:
                                                                    875 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,851 mL
                                                                   -330 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///27/
   Physical Examination
   Gen: well appearing male, appears stated age
   Neck: JVD flat
   CV: RRR, Nl S1 S2. no mrg
   Lungs: clear to auscultation bilaterally.  No rales, wheezes, rhonchi.
   Abd: soft, ND, NT ABS
   Ext: wwp, palpable DP pulses
   Neuro: Alert and oriented to person
   Labs / Radiology
   510 K/uL
   12.2 g/dL
   107 mg/dL
   1.1 mg/dL
   27 mEq/L
   4.4 mEq/L
   20 mg/dL
   106 mEq/L
   140 mEq/L
   36.5 %
   11.1 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
                            [**2166-11-8**]  05:20 AM
   WBC
   10.0
   11.1
   Hct
   37.9
   36.5
   Plt
   [**Telephone/Fax (3) 12094**]
   Cr
   1.0
   1.1
   TropT
   1.00
   2.81
   Glucose
   103
   107
   Other labs: PT / PTT / INR:31.3/30.2/3.1, CK / CKMB /
   Troponin-T:731/44/2.81, Ca++:8.4 mg/dL, Mg++:1.9 mg/dL, PO4:2.6 mg/dL
   Imaging: ECHO:The left atrium is mildly dilated. There is mild
   symmetric left ventricular hypertrophy with normal cavity size. There
   is moderate regional left ventricular systolic dysfunction with
   akinesis of the mid- and distal anterior wall and septum, apex and
   distal inferior segment (mid-LAD territory). The remaining segments
   contract normally (LVEF = 35%). The LV apex is not visualized
   sufficiently for a thrombus to be definitely excluded, although one is
   not seen. Right ventricular chamber size and free wall motion are
   normal. The ascending aorta is mildly dilated. The aortic arch is
   mildly dilated. The aortic valve leaflets (3) are mildly thickened but
   aortic stenosis is not present. No aortic regurgitation is seen. The
   mitral valve leaflets are mildly thickened. Mild (1+) mitral
   regurgitation is seen. There is mild pulmonary artery systolic
   hypertension. There is no pericardial effusion.
   Microbiology: no new micro
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort.
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - start imdur 15mg today and uptitrate
   - morphine, nitro gtt, repeat EKG if pain recurs
   - intervention as outpt
   # PUMP: euvolemic on exam.
   - cont BB, ACEI, Imdur
   # RHYTHM: sinus
   - monitor on tele
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   # Dementia: pt at baseline
   - cont home meds
   FEN: Cardiac
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   CODE: FULL- confirmed with wife
   [**Name (NI) **]: Wife: [**Telephone/Fax (1) 12064**]
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I have also reviewed the notes of Dr(s). [**Name (NI) 2351**] and Pride.
   I would add the following remarks:
   Medical Decision Making
   CK peaked overnight at 1147 and the patient has no further chest pain.
   Echo shows mid to distal ant wall and septum are HK with EF 30-35% s/p
   LAD stenting for ASMI. He continue to have significant lesions in the
   LCx and RCA. He is intermittently confused and quite dysarthric. INR is
   3.1 to prevent mural thrombus. For CAD will continue ASA, Plavix, BB
   and Lisinopril 10 mg QD. Will add nitrates and plan to have the patient
   back in 1 month to stent the RCA and LCx. GI prophylaxis for coumadin,
   PLavix and ASA.
   Above discussed extensively with patient. I have discussed this plan
   with Dr(s). [**Name (NI) 2351**] and Pride.
   Total time spent on patient care: 40 minutes of critical care time.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 88-year-old male with a history of hypertension, stroke, and DVT on coumadin, who presented with an anterior ST-elevation myocardial infarction (STEMI) and was treated with a bare-metal stent (BMS) to the mid-LAD lesion. He has been admitted to the ICU for management of his cardiac condition.

The patient's cardiac enzymes have peaked, and his troponin levels are elevated. His ECHO shows moderate regional left ventricular systolic dysfunction with akinesis of the mid- and distal anterior wall and septum, apex, and distal inferior segment. His LVEF is 35%. He has a history of recurrent pain, which is concerning for recurrent ischemia, but more likely post-infarct discomfort.

The patient's vital signs are stable, with a temperature of 37°C, heart rate of 68 bpm, and blood pressure of 117/58 mmHg. His respiratory rate is 13 breaths per minute, and his oxygen saturation is 94%.

The patient has been started on ASA, Plavix, and Lisinopril, and will be continued on BB, ACEI, and Imdur. He will also be started on nitrates and will have his RCA and LCx stented in the future.

Potential medical complications:

1. Recurrent ischemia: The patient's history of recurrent pain and elevated troponin levels suggest that he may be at risk for recurrent ischemia, which could lead to further cardiac complications.
2. Heart failure: The patient's ECHO shows moderate regional left ventricular systolic dysfunction, which could lead to heart failure if not managed properly.
3. Thrombosis: The patient's history of DVT and his current treatment with coumadin and Plavix put him at risk for thrombosis, which could lead to further cardiac complications.
4. Renal dysfunction: The patient's creatinine level has increased, and he is at risk for further renal dysfunction if not managed properly.
5. Gastrointestinal bleeding: The patient's treatment with ASA, Plavix, and coumadin puts him at risk for gastrointestinal bleeding, which could lead to further complications.
6. Infection: The patient's treatment with antibiotics and his current ICU stay put him at risk for infection, which could lead to further complications.

Based on the patient's condition and potential medical complications, it is essential to closely monitor his cardiac enzymes, ECHO, and vital signs, and to adjust his treatment plan accordingly."
111738.0,207547,2166-11-08 06:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - CP in AM, followed by increasing CK, peaked at 1147, MB at 113
   - ECHO: moderate regional LV systolic dysfxn with akinesis of the mid-
   and distal anterior wall and septum, apex and distal inferior segment
   (mid-LAD territory). LVEF = 35%
   - wasn't urinating, inserted foley
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2166-11-7**] 09:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-8**] 06:52 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 68 (61 - 100) bpm
   BP: 117/58(72) {85/42(58) - 165/87(104)} mmHg
   RR: 13 (12 - 24) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
                  Total In:
                                                                  2,726 mL
                                                                    120 mL
   PO:
                                                                  1,720 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  1,006 mL
   Blood products:
   Total out:
                                                                    875 mL
                                                                    450 mL
   Urine:
                                                                    875 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,851 mL
                                                                   -330 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///27/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   510 K/uL
   12.2 g/dL
   107 mg/dL
   1.1 mg/dL
   27 mEq/L
   4.4 mEq/L
   20 mg/dL
   106 mEq/L
   140 mEq/L
   36.5 %
   11.1 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
                            [**2166-11-8**]  05:20 AM
   WBC
   10.0
   11.1
   Hct
   37.9
   36.5
   Plt
   [**Telephone/Fax (3) 12094**]
   Cr
   1.0
   1.1
   TropT
   1.00
   2.81
   Glucose
   103
   107
   Other labs: PT / PTT / INR:31.3/30.2/3.1, CK / CKMB /
   Troponin-T:731/44/2.81, Ca++:8.4 mg/dL, Mg++:1.9 mg/dL, PO4:2.6 mg/dL
   Imaging: ECHO:The left atrium is mildly dilated. There is mild
   symmetric left ventricular hypertrophy with normal cavity size. There
   is moderate regional left ventricular systolic dysfunction with
   akinesis of the mid- and distal anterior wall and septum, apex and
   distal inferior segment (mid-LAD territory). The remaining segments
   contract normally (LVEF = 35%). The LV apex is not visualized
   sufficiently for a thrombus to be definitely excluded, although one is
   not seen. Right ventricular chamber size and free wall motion are
   normal. The ascending aorta is mildly dilated. The aortic arch is
   mildly dilated. The aortic valve leaflets (3) are mildly thickened but
   aortic stenosis is not present. No aortic regurgitation is seen. The
   mitral valve leaflets are mildly thickened. Mild (1+) mitral
   regurgitation is seen. There is mild pulmonary artery systolic
   hypertension. There is no pericardial effusion.
   Microbiology: no new micro
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   - will need to discuss with family when intervension of the other
   lesions would be appropriate
   # PUMP: euvolemic on exam
   - restart ACEI
   # RHYTHM: sinus
   - monitor on tele
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   # Dementia: pt at baseline
   - cont home meds
   FEN: Cardiac
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   CODE: FULL- confirmed with wife
   [**Name (NI) **]: Wife: [**Telephone/Fax (1) 12064**]
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I have also reviewed the notes of Dr(s). [**Name (NI) 2351**] and Pride.
   I would add the following remarks:
   Medical Decision Making
   CK peaked overnight at 1147 and the patient has no further chest pain.
   Echo shows mid to distal ant wall and septum are HK with EF 30-35% s/p
   LAD stenting for ASMI. He continue to have significant lesions in the
   LCx and RCA. He is intermittently confused and quite dysarthric. INR is
   3.1 to prevent mural thrombus. For CAD will continue ASA, Plavix, BB
   and Lisinopril 10 mg QD. Will add nitrates and plan to have the patient
   back in 1 month to stent the RCA and LCx. GI prophylaxis for coumadin,
   PLavix and ASA.
   Above discussed extensively with patient. I have discussed this plan
   with Dr(s). [**Name (NI) 2351**] and Pride.
   Total time spent on patient care: 40 minutes of critical care time.
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - CP in AM, followed by increasing CK, peaked at 1147, MB at 113
   - ECHO: moderate regional LV systolic dysfxn with akinesis of the mid-
   and distal anterior wall and septum, apex and distal inferior segment
   (mid-LAD territory). LVEF = 35%
   - wasn't urinating, inserted foley
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2166-11-7**] 09:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-8**] 06:52 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 68 (61 - 100) bpm
   BP: 117/58(72) {85/42(58) - 165/87(104)} mmHg
   RR: 13 (12 - 24) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
                  Total In:
                                                                  2,726 mL
                                                                    120 mL
   PO:
                                                                  1,720 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  1,006 mL
   Blood products:
   Total out:
                                                                    875 mL
                                                                    450 mL
   Urine:
                                                                    875 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,851 mL
                                                                   -330 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///27/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   510 K/uL
   12.2 g/dL
   107 mg/dL
   1.1 mg/dL
   27 mEq/L
   4.4 mEq/L
   20 mg/dL
   106 mEq/L
   140 mEq/L
   36.5 %
   11.1 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
                            [**2166-11-8**]  05:20 AM
   WBC
   10.0
   11.1
   Hct
   37.9
   36.5
   Plt
   [**Telephone/Fax (3) 12094**]
   Cr
   1.0
   1.1
   TropT
   1.00
   2.81
   Glucose
   103
   107
   Other labs: PT / PTT / INR:31.3/30.2/3.1, CK / CKMB /
   Troponin-T:731/44/2.81, Ca++:8.4 mg/dL, Mg++:1.9 mg/dL, PO4:2.6 mg/dL
   Imaging: ECHO:The left atrium is mildly dilated. There is mild
   symmetric left ventricular hypertrophy with normal cavity size. There
   is moderate regional left ventricular systolic dysfunction with
   akinesis of the mid- and distal anterior wall and septum, apex and
   distal inferior segment (mid-LAD territory). The remaining segments
   contract normally (LVEF = 35%). The LV apex is not visualized
   sufficiently for a thrombus to be definitely excluded, although one is
   not seen. Right ventricular chamber size and free wall motion are
   normal. The ascending aorta is mildly dilated. The aortic arch is
   mildly dilated. The aortic valve leaflets (3) are mildly thickened but
   aortic stenosis is not present. No aortic regurgitation is seen. The
   mitral valve leaflets are mildly thickened. Mild (1+) mitral
   regurgitation is seen. There is mild pulmonary artery systolic
   hypertension. There is no pericardial effusion.
   Microbiology: no new micro
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   - will need to discuss with family when intervension of the other
   lesions would be appropriate
   # PUMP: euvolemic on exam
   - restart ACEI
   # RHYTHM: sinus
   - monitor on tele
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   # Dementia: pt at baseline
   - cont home meds
   FEN: Cardiac
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   CODE: FULL- confirmed with wife
   [**Name (NI) **]: Wife: [**Telephone/Fax (1) 12064**]
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I have also reviewed the notes of Dr(s). [**Name (NI) 2351**] and Pride.
   I would add the following remarks:
   Medical Decision Making
   CK peaked overnight at 1147 and the patient has no further chest pain.
   Echo shows mid to distal ant wall and septum are HK with EF 30-35% s/p
   LAD stenting for ASMI. He continue to have significant lesions in the
   LCx and RCA. He is intermittently confused and quite dysarthric. INR is
   3.1 to prevent mural thrombus. For CAD will continue ASA, Plavix, BB
   and Lisinopril 10 mg QD. Will add nitrates and plan to have the patient
   back in 1 month to stent the RCA and LCx. GI prophylaxis for coumadin,
   PLavix and ASA.
   Above discussed extensively with patient. I have discussed this plan
   with Dr(s). [**Name (NI) 2351**] and Pride.
   Total time spent on patient care: 40 minutes of critical care time.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 88-year-old male admitted to the ICU with a diagnosis of acute myocardial infarction (STEMI) and post-myocardial infarction syndrome (PMI). He underwent percutaneous coronary intervention (PCI) with stenting of the mid-LAD lesion. The patient's cardiac enzymes peaked overnight, with a creatine kinase (CK) level of 1147 and a troponin-T level of 2.81. His left ventricular ejection fraction (LVEF) is 35%. He has mild symmetric left ventricular hypertrophy and moderate regional left ventricular systolic dysfunction with akinesis of the mid- and distal anterior wall and septum.

The patient's vital signs are stable, with a heart rate of 68 beats per minute, blood pressure of 117/58 mmHg, and oxygen saturation of 94%. He is receiving morphine sulfate for pain management and has a Foley catheter in place for urinary drainage.

The patient has a history of hypertension, stroke, and deep vein thrombosis (DVT) on coumadin. He is also taking aspirin, clopidogrel, lisinopril, and metoprolol for his cardiovascular conditions.

Potential Medical Complications:

1. Recurrent ischemia: The patient's recurrent chest pain is concerning for recurrent ischemia, which could lead to further cardiac complications.
2. Heart failure: The patient's LVEF of 35% and moderate regional left ventricular systolic dysfunction increase his risk of developing heart failure.
3. Arrhythmias: The patient's history of hypertension and DVT on coumadin increase his risk of developing arrhythmias, such as atrial fibrillation or ventricular tachycardia.
4. Thrombosis: The patient's history of DVT and his current treatment with coumadin increase his risk of developing thrombosis, which could lead to pulmonary embolism or stroke.
5. Infection: The patient's immunosuppressed state and his history of dementia increase his risk of developing infections, such as pneumonia or urinary tract infections.
6. Gastrointestinal bleeding: The patient's treatment with anticoagulants and antiplatelet agents increases his risk of developing gastrointestinal bleeding.
7. Renal insufficiency: The patient's history of hypertension and his current treatment with ACE inhibitors and lisinopril increase his risk of developing renal insufficiency.
8. Cognitive decline: The patient's history of dementia and his current treatment with anticoagulants and antiplatelet agents increase his risk of developing cognitive decline.

Recommendations:

1. Continue monitoring the patient's cardiac enzymes and vital signs to detect any changes in his condition.
2. Adjust the patient's medication regimen as needed to manage his cardiovascular conditions.
3. Monitor the patient's blood pressure and heart rate to detect any changes in his condition.
4. Consider adding medications to prevent recurrent ischemia and heart failure.
5. Monitor the patient's renal function and adjust his medication regimen as needed to prevent renal insufficiency.
6. Monitor the patient's cognitive function and adjust his medication regimen as needed to prevent cognitive decline.
7. Consider adding medications to prevent thrombosis and infection.
8. Monitor the patient's gastrointestinal symptoms and adjust his medication regimen as needed to prevent gastrointestinal bleeding."
111738.0,207547,2166-11-08 06:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - CP in AM, followed by increasing CK, peaked at 1147, MB at 113
   - ECHO: moderate regional LV systolic dysfxn with akinesis of the mid-
   and distal anterior wall and septum, apex and distal inferior segment
   (mid-LAD territory). LVEF = 35%
   - wasn't urinating, inserted foley
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2166-11-7**] 09:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-8**] 06:52 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 68 (61 - 100) bpm
   BP: 117/58(72) {85/42(58) - 165/87(104)} mmHg
   RR: 13 (12 - 24) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
                  Total In:
                                                                  2,726 mL
                                                                    120 mL
   PO:
                                                                  1,720 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  1,006 mL
   Blood products:
   Total out:
                                                                    875 mL
                                                                    450 mL
   Urine:
                                                                    875 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,851 mL
                                                                   -330 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///27/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   510 K/uL
   12.2 g/dL
   107 mg/dL
   1.1 mg/dL
   27 mEq/L
   4.4 mEq/L
   20 mg/dL
   106 mEq/L
   140 mEq/L
   36.5 %
   11.1 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
                            [**2166-11-8**]  05:20 AM
   WBC
   10.0
   11.1
   Hct
   37.9
   36.5
   Plt
   [**Telephone/Fax (3) 12094**]
   Cr
   1.0
   1.1
   TropT
   1.00
   2.81
   Glucose
   103
   107
   Other labs: PT / PTT / INR:31.3/30.2/3.1, CK / CKMB /
   Troponin-T:731/44/2.81, Ca++:8.4 mg/dL, Mg++:1.9 mg/dL, PO4:2.6 mg/dL
   Imaging: ECHO:The left atrium is mildly dilated. There is mild
   symmetric left ventricular hypertrophy with normal cavity size. There
   is moderate regional left ventricular systolic dysfunction with
   akinesis of the mid- and distal anterior wall and septum, apex and
   distal inferior segment (mid-LAD territory). The remaining segments
   contract normally (LVEF = 35%). The LV apex is not visualized
   sufficiently for a thrombus to be definitely excluded, although one is
   not seen. Right ventricular chamber size and free wall motion are
   normal. The ascending aorta is mildly dilated. The aortic arch is
   mildly dilated. The aortic valve leaflets (3) are mildly thickened but
   aortic stenosis is not present. No aortic regurgitation is seen. The
   mitral valve leaflets are mildly thickened. Mild (1+) mitral
   regurgitation is seen. There is mild pulmonary artery systolic
   hypertension. There is no pericardial effusion.
   Microbiology: no new micro
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   - will need to discuss with family when intervension of the other
   lesions would be appropriate
   # PUMP: euvolemic on exam
   - restart ACEI
   # RHYTHM: sinus
   - monitor on tele
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   # Dementia: pt at baseline
   - cont home meds
   FEN: Cardiac
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   CODE: FULL- confirmed with wife
   [**Name (NI) **]: Wife: [**Telephone/Fax (1) 12064**]
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - CP in AM, followed by increasing CK, peaked at 1147, MB at 113
   - ECHO: moderate regional LV systolic dysfxn with akinesis of the mid-
   and distal anterior wall and septum, apex and distal inferior segment
   (mid-LAD territory). LVEF = 35%
   - wasn't urinating, inserted foley
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2166-11-7**] 09:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-8**] 06:52 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 68 (61 - 100) bpm
   BP: 117/58(72) {85/42(58) - 165/87(104)} mmHg
   RR: 13 (12 - 24) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
                  Total In:
                                                                  2,726 mL
                                                                    120 mL
   PO:
                                                                  1,720 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  1,006 mL
   Blood products:
   Total out:
                                                                    875 mL
                                                                    450 mL
   Urine:
                                                                    875 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,851 mL
                                                                   -330 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///27/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   510 K/uL
   12.2 g/dL
   107 mg/dL
   1.1 mg/dL
   27 mEq/L
   4.4 mEq/L
   20 mg/dL
   106 mEq/L
   140 mEq/L
   36.5 %
   11.1 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
                            [**2166-11-8**]  05:20 AM
   WBC
   10.0
   11.1
   Hct
   37.9
   36.5
   Plt
   [**Telephone/Fax (3) 12094**]
   Cr
   1.0
   1.1
   TropT
   1.00
   2.81
   Glucose
   103
   107
   Other labs: PT / PTT / INR:31.3/30.2/3.1, CK / CKMB /
   Troponin-T:731/44/2.81, Ca++:8.4 mg/dL, Mg++:1.9 mg/dL, PO4:2.6 mg/dL
   Imaging: ECHO:The left atrium is mildly dilated. There is mild
   symmetric left ventricular hypertrophy with normal cavity size. There
   is moderate regional left ventricular systolic dysfunction with
   akinesis of the mid- and distal anterior wall and septum, apex and
   distal inferior segment (mid-LAD territory). The remaining segments
   contract normally (LVEF = 35%). The LV apex is not visualized
   sufficiently for a thrombus to be definitely excluded, although one is
   not seen. Right ventricular chamber size and free wall motion are
   normal. The ascending aorta is mildly dilated. The aortic arch is
   mildly dilated. The aortic valve leaflets (3) are mildly thickened but
   aortic stenosis is not present. No aortic regurgitation is seen. The
   mitral valve leaflets are mildly thickened. Mild (1+) mitral
   regurgitation is seen. There is mild pulmonary artery systolic
   hypertension. There is no pericardial effusion.
   Microbiology: no new micro
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   - will need to discuss with family when intervension of the other
   lesions would be appropriate
   # PUMP: euvolemic on exam
   - restart ACEI
   # RHYTHM: sinus
   - monitor on tele
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   # Dementia: pt at baseline
   - cont home meds
   FEN: Cardiac
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   CODE: FULL- confirmed with wife
   [**Name (NI) **]: Wife: [**Telephone/Fax (1) 12064**]
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 88-year-old male with a significant past medical history of hypertension, stroke, deep vein thrombosis (DVT) on coumadin, and dementia. He presented with a ST-elevation myocardial infarction (STEMI) and was taken to the catheterization laboratory where a bare-metal stent (BMS) was placed in the mid-LAD lesion.

The patient's current condition is characterized by:

* Recurrent chest pain, likely due to post-infarct discomfort
* Moderate regional left ventricular systolic dysfunction with akinesis of the mid- and distal anterior wall and septum, apex, and distal inferior segment (mid-LAD territory)
* Mild symmetric left ventricular hypertrophy with normal cavity size
* Mild pulmonary artery systolic hypertension
* Mild mitral regurgitation
* Normal right ventricular chamber size and free wall motion

Potential medical complications that can arise from the patient's condition include:

* Recurrent ischemia or infarction due to residual stenosis in the ramus and mid-RCA
* Development of heart failure due to the moderate regional left ventricular systolic dysfunction
* Pulmonary edema due to the mild pulmonary artery systolic hypertension
* Mitral regurgitation leading to heart failure or arrhythmias
* Deep vein thrombosis or pulmonary embolism due to the patient's history of DVT and ongoing anticoagulation with coumadin
* Nephrotoxicity due to the patient's history of hypertension and chronic kidney disease
* Gastrointestinal bleeding due to the patient's history of dementia and potential use of antiplatelet agents

The patient's laboratory results show:

* Elevated troponin-T levels (2.81 ng/mL) indicating ongoing myocardial injury
* Elevated creatine kinase (CK) levels (1147 IU/L) indicating muscle damage
* Elevated lactate dehydrogenase (LDH) levels (731 IU/L) indicating tissue damage
* Elevated white blood cell count (11.1 K/uL) indicating inflammation
* Elevated creatinine levels (1.1 mg/dL) indicating kidney dysfunction

The patient's medications include:

* Aspirin 325mg daily
* Plavix 75mg daily for 1 year
* Lipitor 80mg daily
* Metoprolol 37.5mg TID for blood pressure control
* Lisinopril with holding parameters
* Morphine sulfate for pain management
* Nitroglycerin for pain management

The patient's plan of care includes:

* Continuation of aspirin and plavix for 1 year
* Restart of lisinopril with holding parameters
* Monitoring of creatinine levels and avoidance of nephrotoxins
* Continuation of metoprolol for blood pressure control
* Monitoring of troponin-T levels and creatine kinase levels
* Continuation of pain management with morphine sulfate and nitroglycerin
* Monitoring of white blood cell count and platelet count
* Continuation of anticoagulation with coumadin for DVT prophylaxis
* Monitoring of international normalized ratio (INR) for coumadin therapy
* Monitoring of hemoglobin and hematocrit levels for anemia and bleeding risk."
